新型实验性药物或将改变癌症患者护理方式——独立报
New experimental drug could transform care for cancer patients - The Independent
生物技术与制药领域的最新动态
New experimental drug could transform care for cancer patients - The Independent
Roche Shares Rise After Breast-Cancer Pill Shows Positive Results in Trial - The Wall Street Journal
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? - simplywall.st
Roche reports positive Phase III data of giredestrant for breast cancer - Clinical Trials Arena
Roche oral drug shown to keep breast cancer at bay, boosting shares - Reuters
Leadership Perspectives: Illumina leads the industry in genomic AI - Illumina
Amylin could reign supreme in the next wave of obesity drugs
High-resolution climate model forecasts a wet, turbulent future
Roche Gives Glimpse of Cancer Genomics Potential of New Axelios Sequencer - GenomeWeb
Developing a path forward in cancer cachexia
What Does Agilent Technologies, Inc.'s (NYSE:A) Share Price Indicate? - Yahoo Finance
The next leap in Alzheimer’s R&D is coming, but not around the corner
10x Genomics (TXG) Price Target Increased by 10.47% to 16.66 - Nasdaq
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - MSN
How Lonza Group AG (Common Stock) (LO3A) stock reacts to stronger dollar - Portfolio Risk Report & Free Long-Term Investment Growth Plans - newser.com
10x Genomics (TXG): Assessing Valuation After Recent 34% Share Price Rise - simplywall.st
Is Illumina Inc. (ILU) stock a buy on weakness - Portfolio Performance Report & Accurate Buy Signal Alerts - newser.com
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - Yahoo Finance
10x Genomics GC Who Led Rule Of Law Effort To Retire In '26 - Law360
There's Reason For Concern Over 10x Genomics, Inc.'s (NASDAQ:TXG) Massive 42% Price Jump - simplywall.st